Literature DB >> 28292533

Assessment of hydration status using bioelectrical impedance vector analysis in critical patients with acute kidney injury.

Ana Cláudia da Rosa Hise1, Maria Cristina Gonzalez2.   

Abstract

BACKGROUND & AIMS: The state of hyperhydration in critically ill patients with acute kidney injury (AKI) is associated with increased mortality. Bioelectrical impedance vector analysis (BIVA) appears to be a viable method to access the fluid status of critical patients but has never been evaluated in critical patients with AKI. The objective of this study is to evaluate the hydration status measured using BIVA in critical patients under intensive care at the time of AKI diagnosis and to correlate this measurement with mortality.
METHODS: We assessed the fluid status measured using BIVA in 224 critical patients at the time of AKI diagnosis and correlated it with mortality. To interpret the results, BIVA Software 2002 was used to plot the data from the patients studied on the 95% confidence ellipses of the RXc plane for comparisons between groups (non-survivors, survivors). Variables such as mechanical ventilation, vasoactive drug, and sepsis, among others, were collected.
RESULTS: The impedance vector analysis conducted using BIVA Software 2002 indicated changes in the body compositions of patients according to the 95% confidence ellipse between the vectors R/H and Xc/H of the group of survivors and the group of deceased patients. Hotelling's test (T2 = 21.2) and the F test (F = 10.6) revealed significant differences (p < 0.001) between the two groups. These results demonstrate that patients who died presented with a greater hydration volume at the time of AKI diagnosis compared with those who survived. In addition to the hydration status measured using BIVA, the following were also correlated with death: diagnosis at hospitalization, APACHE II score, length of hospital stay, RIFLE score, maximum organ failure, sepsis type, hemoglobin, and AF.
CONCLUSIONS: The fluid status assessment measured using BIVA significantly demonstrated the difference in hydration between survivors and non-survivors among critically ill patients with AKI.
Copyright © 2017 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Bioelectrical impedance analysis; Critical patient; Fluid status; Prognostic factor

Mesh:

Year:  2017        PMID: 28292533     DOI: 10.1016/j.clnu.2017.02.016

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  6 in total

1.  The Use of Bioelectrical Impedance Analysis Measures for Predicting Clinical Outcomes in Critically Ill Children.

Authors:  Zi-Hong Xiong; Xue-Mei Zheng; Guo-Ying Zhang; Meng-Jun Wu; Yi Qu
Journal:  Front Nutr       Date:  2022-06-06

Review 2.  Ultrafiltration in critically ill patients treated with kidney replacement therapy.

Authors:  Raghavan Murugan; Rinaldo Bellomo; Paul M Palevsky; John A Kellum
Journal:  Nat Rev Nephrol       Date:  2020-11-11       Impact factor: 28.314

Review 3.  Kidney Replacement Therapy for Fluid Management.

Authors:  Vikram Balakumar; Raghavan Murugan
Journal:  Crit Care Clin       Date:  2021-02-13       Impact factor: 3.598

4.  Bioelectrical impedance vector analysis evaluates cellularity and hydration in cirrhotic patients.

Authors:  Sabrina Alves Fernandes; Lara Rigon Leonhardt; Daniella Miranda da Silva; Fernanda Donner Alves; Cláudio Augusto Marroni
Journal:  World J Hepatol       Date:  2020-12-27

5.  Bioelectrical impedance analysis versus physician adjustment in acute kidney injury patients to reduce intradialytic hypotension: A randomized controlled trial.

Authors:  Nutcharin Kamjohnjiraphunt; Thananda Trakarnvanich
Journal:  Ann Med Surg (Lond)       Date:  2022-07-31

6.  Assessment of Fluid Status by Bioimpedance Analysis and Central Venous Pressure Measurement and Their Association with the Outcomes of Severe Acute Kidney Injury.

Authors:  Justina Karpavičiūtė; Inga Skarupskienė; Vilma Balčiuvienė; Rūta Vaičiūnienė; Edita Žiginskienė; Inga Arūnė Bumblytė
Journal:  Medicina (Kaunas)       Date:  2021-05-22       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.